[Progress in the treatment of invasive mucinous adenocarcinoma of the lung].

Invasive mucinous adenocarcinoma belongs to a specific subtype of lung adenocarcinoma, The histological characteristics of the tumor are rich in mucus, with unique clinicopathological features and immunophenotype. There is no specific in-depth study on the etiology and pathogenesis of IMA, and it is generally considered to be the same as common lung adenocarcinoma. Due to its relatively low incidence, there are currently few large-scale studies on IMA, The purpose of this study is to explore the therapeutic strategies of IMA patients from the existing research advances, including surgical resection, chemotherapy, targeted therapy, immunotherapy, and novel therapeutic approaches and their combination, and to explore the impact of these recent therapeutic advances on prognosis.